Beyond Longevity

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switzerland. He explains why many brands misunderstand the German-speaking market: distribution and pharmacy listings alone do not create demand, pharmacies are not straightforward sales channels, and scep...

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientific discovery in ways that would have been difficult to imagine just a few years ago. But AI is not replacing scientists. If anything, it is making human expertise, judgement, and scientific rigour mor...

Beyond Longevity interviews Kyle Holbert, COO and co-founder of Longevity Centres of America, about how unexplained fatigue, brain fog, depression, anxiety, joint pain and gut issues derailed his health despite a healthy lifestyle and years of searching for answers. After seeing multiple GPs and therapists who either dismissed his symptoms or could not identify a cause, Kyle discovered he had seve...

In this episode of Beyond Longevity, Daphna speaks with Nikolina Lauc, CEO and co-founder of GlycanAge, about glycobiology, immune ageing, and the role of chronic inflammation in ageing. Nikolina explains why glycans, the complex sugar structures attached to our antibodies, may offer one of the clearest windows into the state of the immune system. The conversation explores “inflammaging”, the idea...

Daphna sat down with Alan Graves, founder of DoNotAge, for an in-depth conversation about what it takes to make longevity science more credible, more collaborative and more accessible. After a serious health decline in his late twenties, Alan entered the longevity field after learning that ageing may be more malleable than he had once thought. He went on to build DoNotAge as a self-funded health r...

In this episode of Beyond Longevity, Daphna speaks with Dr David Cox, a health journalist (BBC, The Guardian, The Telegraph, NBC News and others), who holds a PhD in neuroscience from the University of Cambridge and is the author of The Age Code , about how diet, ultra-processed foods and the modern food environment shape biological ageing. Dr David argues that the longevity conversation often foc...

Supplements promise a lot: mitochondrial support, better brain health, healthier gut function, anti-ageing benefits and more. But how much of that is real science, and how much is simply clever wording on a label? In this episode of Beyond Longevity, Dr Luke Bucci, PhD, Chief Scientific Officer at Juvenon, brings both a scientist’s eye and decades of experience in the supplement industry to one of...

This week on Beyond Longevity, I am joined by Dr Herna de Wit, CEO and Founder of Omnisci Consulting, with a PhD in Biochemistry and an LLB in Law. Dr Herna brings a very unusual and valuable combination to the longevity conversation: deep scientific training, legal expertise and hands-on experience advising companies in the health, biotech and longevity space. Longevity is full of exciting scienc...

On Beyond Longevity, Dr Filippo Ongaro, medical doctor, entrepreneur, and strategic advisor, shares how nearly eight years working with astronauts at the European Space Agency shaped the way he thinks about ageing. In space, the body can lose muscle, bone and resilience at a frightening speed. Stress, sleep disruption, nutrition, movement and circadian misalignment are not lifestyle details. They...

Michael A. Clinton, former President of Hearst Magazines. Michael spent four decades at the top of the publishing world, including as President and Publishing Director of Hearst Magazines, before turning his attention to one of the biggest questions of our time. If many of us are likely to live longer than previous generations, how do we make the second half of life not just longer, but more inten...

What does good prevention actually look like, and is the longevity industry helping people live better, or simply making health feel more complicated? In this episode of Beyond Longevity, Daphna speaks with Niko Hems, Operations Lead at YEARS, a longevity clinic in Berlin, Germany. Niko brings a rare perspective to the conversation. He works inside the longevity field, but he is not afraid to chal...

In this ViVE conference bonus episode of Beyond Longevity, recorded live at the ViVE event in Los Angeles, the conversation explores how BioAro is seeking to bring different strands of personalised health data together within a single longevity platform. Brock Hay explains BioAro’s approach to integrating genomics, microbiome testing, biomarker analysis, AI-driven interpretation, and personalized...

On Beyond Longevity, Corinne Briaud Manon discusses women’s healthspan through the lenses of science, consumer trust and commercial execution, drawing on her experience in major corporates and her work across Green Marlin, which advises health and longevity startups, and LongHER, a women’s healthspan community platform. She explains how the two initiatives connect, including how startups can test...

Professor Lorna Harries has spent more than two decades studying why cells age and what might be done about it. In this episode, she explains one of the most overlooked mechanisms in ageing biology, RNA splicing. When cells lose control of this process, they become stressed, dysfunctional and can tip into senescence, a state that contributes to ageing across almost every organ system. She explains...

Recorded at the 2026 VIVE conference in Los Angeles, this Beyond Longevity mini-series episode features Mark Zemel, co-founder and CEO of Retia Medical, discussing the company’s hemodynamic monitoring technology that turns continuous bedside physiological signals into real-time clinical insights for high-risk surgery and critical care. Marc explains Retia’s aim to detect early deterioration, guide...

This week’s guest is Avivah Wittenberg-Cox. Avivah advises leaders on gender and generational balance, the future of work, and the longevity economy. She hosts the podcast 4-Quarter Lives, publishes the Substack Elderberries, and writes regularly for Forbes and Harvard Business Review. She is Visiting Faculty at Oxford’s Saïd Business School, co-directs the Longevity Leadership Programme at Católi...

In this episode, Dr Jin-Xiong She, a scientist with more than 400 publications, over 20,000 citations, and more than $100 million in research funding, explains why he left the top tier of academic medicine to pursue something more urgent: finding better ways to detect decline early and protect healthspan before disease takes hold. He shares what nearly 100,000 NAD tests have uncovered and why he b...

What does it take to turn longevity science into real-world policy? In this episode, Daphna speaks with Dr Ilia Stambler, historian of longevity, published author, Chair of the International Longevity Alliance (ILA), and Chief Science Officer and Chairman of Vetek (Seniority) Association, about why advocacy and ecosystem-building may be just as important as the science itself. Dr Stambler shares h...

In this episode, Daphna sits down with Elio, co-founder of LongevAI, a platform using artificial intelligence to help longevity clinics analyse biomarker data, streamline documentation, and build personalised client plans. With a background in computer science and a lifelong passion for health optimisation, Elio offers a grounded, honest perspective on what AI in longevity medicine can do today, a...

Dr Bradley Elliott — physiologist, university lecturer, and a trustee and Communications Lead at the British Society for Research on Ageing — joins host Daphna for a refreshingly honest conversation about what longevity science actually knows and what we still cannot explain. This episode cuts through the certainty. We talk about biomarkers and biological age, why many measurements may be tracking...

In this episode, I sit down with Dr Brendan Khong, a London-based aesthetic physician and regenerative medicine advocate, for a practical conversation about what it really means to age well, starting with the skin, but quickly expanding into whole-body biology. The central theme is a shift now reshaping aesthetic medicine: moving away from surface-level fixes and toward addressing the underlying d...

What happens to your financial plan when you live to 100? Most pension systems were built around an ~80-year life expectancy. Much of today’s financial advice still follows a linear life-stage model. And many businesses have not yet reckoned with the fact that both their customers and their workforce are ageing in ways that will reshape everything. In this episode of Beyond Longevity, I am joined...

What can a tiny worm tell us about human ageing, and could gut bacteria hold the key to a longer, healthier life? In this episode of Beyond Longevity , we sit down with Professor David Weinkove: Chair of the British Society for Research on Ageing (BSRA), Professor at Durham University, and Co-founder and CSO of Magnitude Biosciences. David's lab uses the short-lived nematode C. elegans to run fast...

What if the conditions we treat in our fifties and sixties which were set in motion decades earlier, would have been spotted, and shifted, far sooner? In this episode of Beyond Longevity, I sit down with Dr Mayoni Gooneratne, Founder and Medical Director of Human Health and Skin Fit Clinics, and Vice President of the British College of Functional Medicine. After years as an NHS colorectal and pelv...

In this episode of Beyond Longevity, I am joined by Dr Angus Perry, a practising GP, clinical AI builder, and performance-medicine enthusiast with experience supporting Formula One teams and elite athletes. Dr Angus is focused on closing the gap between what preventive medicine can achieve and what is realistic inside a ten-minute GP appointment. He shares the path that led him here: a childhood a...